Skip to main content

Table 7 Association between GPs' awareness of depressive symptomatology, depression treatment and HRQOL

From: General practitioners’ awareness of depressive symptomatology is not associated with quality of life in heart failure patients – cross-sectional results of the observational RECODE-HF Study

  Model 1 Model 2 Model 3
Variable F P-Value F P-Value F P-Value
Corrected model 8.968 <0.001 9.107 <0.001 7.602 <0.001
Constant 96.808 <0.001 98.089 <0.001 97.612 <0.001
GPs' awareness of depressive symptomatology 0.122 0.727    0.436 0.510
Utilisation of prescription antidepressants or psychotherapy    1.303 0.254 1.519 0.218
GPs' awareness of depressive symptomatology* Utilisation of prescription antidepressants or psychotherapy      0.087 0.768
Age 4.021 0.045 3.394 0.066 3.512 0.062
Sex (female) 1.440 0.231 1.747 0.187 1.597 0.207
Education 3.052 0.048 3.057 0.048 3.077 0.047
NYHA Class 10.399 <0.001 10.327 <0.001 9.942 <0.001
Comorbidity score 0.447 0.504 0.285 0.594 0.273 0.601
PHQ-9 Score 33.030 <0.001 35.974 <0.001 34.418 <0.001
  N = 503; R2 = 0.154 N = 503; R2 = 0.156 N = 503; R2 = 0.157
  1. Univariate ANCOVA with endpoint HRQOL (EQ-5D VAS) in patients screened positive for depressive symptomatology P(+). Regarding utilisation of prescription antidepressants or psychotherapy, cases with utilisation were compared with all other cases (no utilisation and cases with no available information, respectively)